Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 276 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype.
Shanker S, Hasserjian RP, Madanat Y, Weinberg OK, Cantu MD
Am J Hematol, 30 Oct 2024
Cited by: 0 articles | PMID: 39475382
Add to export list
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.
Komrokji RS, Lanino L, Ball S, Bewersdorf JP, Marchetti M, Maggioni G, Travaglino E, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Diez-Campelo M, Singh A, Jain AG, Aguirre LE, Tinsley-Vance SM, Schwabkey ZI, Chan O, Xie Z, [...] International Consortium on Myelodysplastic Syndromes
Lancet Haematol, 11(11):e862-e872, 09 Oct 2024
Cited by: 0 articles | PMID: 39393368
Add to export list Review
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology.
Della Porta MG, Bewersdorf JP, Wang YH, Hasserjian RP
Histopathology, 25 Oct 2024
Cited by: 0 articles | PMID: 39450427
Add to export list Review
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).
Aakash F, Gisriel SD, Zeidan AM, Bennett JM, Bejar R, Bewersdorf JP, Borate UM, Boultwood J, Brunner AM, Buckstein R, Carraway HE, Churpek JE, Daver NG, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Garcia-Manero G, Gore SD, [...] Loghavi S
Mod Pathol, 37(12):100615, 23 Sep 2024
Cited by: 0 articles | PMID: 39322118
Add to export list Review
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.
Bernard E, Hasserjian RP, Greenberg PL, Arango Ossa JE, Creignou M, Tuechler H, Gutierrez-Abril J, Domenico D, Medina-Martinez JS, Levine M, Liosis K, Farnoud N, Sirenko M, Jädersten M, Germing U, Sanz G, van de Loosdrecht AA, Nannya Y, Kosmider O, [...] Papaemmanuil E
Blood, 144(15):1617-1632, 01 Oct 2024
Cited by: 0 articles | PMID: 38958467 | PMCID: PMC11487646
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.
Crane GM, Geyer JT, Thakral B, Wang SA, Wool GD, Li KD, Davis AR, Boiocchi L, Bosler D, Bueso-Ramos CE, Arber DA, George TI, Bagg A, Hasserjian RP, Orazi A, Hsi ED, Rogers HJ
Am J Clin Pathol, 162(3):233-242, 01 Sep 2024
Cited by: 0 articles | PMID: 38597584
Add to export list
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
Döhner H, DiNardo CD, Wei AH, Löwenberg B, Appelbaum F, Craddock C, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele GJ, Röllig C, Sierra J, Stein EM, [...] Wierzbowska A
Blood, blood.2024025409, 12 Aug 2024
Cited by: 1 article | PMID: 39133932
Add to export list
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.
Xiao W, Nardi V, Stein E, Hasserjian RP
J Hematol Oncol, 17(1):56, 29 Jul 2024
Cited by: 0 articles | PMID: 39075565 | PMCID: PMC11287910
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
Campo E, Dierickx D, Dirnhofer S, Dunleavy K, Gaulard P, Hasserjian RP, Jaffe ES, Kim WS, King RL, Lim MS, Ott G, Piris MA, Salles G, Siebert R
J Clin Oncol, 42(27):3177-3182, 17 Jul 2024
Cited by: 0 articles | PMID: 39018505
Add to export list
Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.
Menke JR, Aypar U, Bangs CD, Cook SL, Gupta S, Hasserjian RP, Kong CS, Lin O, Long SR, Ly A, Menke JAS, Natkunam Y, Ruiz-Cordero R, Spiteri E, Ye J, Zadeh SL, Gratzinger DA
Front Oncol, 14:1408238, 06 Jun 2024
Cited by: 0 articles | PMID: 38903717 | PMCID: PMC11187077
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
Yin CC, Tam W, Walker SM, Kaur A, Ouseph MM, Xie W, K Weinberg O, Li P, Zuo Z, Routbort MJ, Chen S, Medeiros LJ, George TI, Orazi A, Arber DA, Bagg A, Hasserjian RP, Wang SA
Haematologica, 109(6):1825-1835, 01 Jun 2024
Cited by: 1 article | PMID: 37981812
Add to export list
Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R, Bisig B, Guey B, Missiaglia E, Cairoli A, Omoumi P, Letovanec I, Ferry JA, Hasserjian RP, de Leval L
Mod Pathol, 37(4):100440, 28 Jan 2024
Cited by: 0 articles | PMID: 38290600
Add to export list
Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP, Germing U, Malcovati L
Blood, 142(26):2247-2257, 01 Dec 2023
Cited by: 6 articles | PMID: 37774372
Add to export list
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S, DeAngelo DJ, Garcia JS, Hasserjian RP, Hergott CB, Lane AA, Lovitch SB, Lucas F, Luskin MR, Morgan EA, Pinkus GS, Pozdnyakova O, Rodig SJ, Shanmugam V, Tsai HK, Winer ES, Zemmour D, Kim AS
Mod Pathol, 37(1):100352, 13 Oct 2023
Cited by: 1 article | PMID: 37839675
Add to export list
Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury.
Jagannath S, Anderson MA, Yee AJ, Hasserjian RP
N Engl J Med, 389(12):1133-1143, 01 Sep 2023
Cited by: 0 articles | PMID: 37733312
Add to export list
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.
Foucar K, Bagg A, Bueso-Ramos CE, George T, Hasserjian RP, Hsi ED, Orazi A, Tam W, Wang SA, Weinberg OK, Arber DA
Am J Clin Pathol, 160(4):365-393, 01 Oct 2023
Cited by: 0 articles | PMID: 37391178
Add to export list
Morphologic Characteristics of Myelodysplastic Syndromes.
Yuen LD, Hasserjian RP
Clin Lab Med, 43(4):577-596, 09 Aug 2023
Cited by: 2 articles | PMID: 37865504
Add to export list Review
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Stahl M, Bewersdorf JP, Xie Z, Porta MGD, Komrokji R, Xu ML, Abdel-Wahab O, Taylor J, Steensma DP, Starczynowski DT, Sekeres MA, Sanz G, Sallman DA, Roboz GJ, Platzbecker U, Patnaik MM, Padron E, Odenike O, Nimer SD, [...] Zeidan AM
Blood Rev, 62:101128, 19 Aug 2023
Cited by: 4 articles | PMID: 37704469
Add to export list Review
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Hochman MJ, Othus M, Hasserjian RP, Ambinder A, Brunner A, Percival MM, Hourigan CS, Swords R, DeZern AE, Estey EH, Karp JE
Leukemia, 37(9):1915-1918, 31 Jul 2023
Cited by: 2 articles | PMID: 37524919 | PMCID: PMC10457181
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight.
Foy BH, Stefely JA, Bendapudi PK, Hasserjian RP, Al-Samkari H, Louissaint A, Fitzpatrick MJ, Hutchison B, Mow C, Collins J, Patel HR, Patel CH, Patel N, Ho SN, Kaufman RM, Dzik WH, Higgins JM, Makar RS
Blood Adv, 7(16):4621-4630, 01 Aug 2023
Cited by: 4 articles | PMID: 37146262 | PMCID: PMC10448422
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA, Orazi A, Gotlib J, Reiter A, Tzankov A, Hasserjian RP, Arber DA, Tefferi A
Am J Hematol, 98(8):1286-1306, 07 Jun 2023
Cited by: 7 articles | PMID: 37283522
Add to export list Review
Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.
Weinberg OK, Cantu MD, Gagan J, Madanat YF, Arber DA, Hasserjian RP
EJHaem, 4(3):760-764, 18 May 2023
Cited by: 1 article | PMID: 37601841 | PMCID: PMC10435713
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
Stahl M, Abdel-Wahab O, Wei AH, Savona MR, Xu ML, Xie Z, Taylor J, Starczynowski D, Sanz GF, Sallman DA, Santini V, Roboz GJ, Patnaik MM, Padron E, Odenike O, Nazha A, Nimer SD, Majeti R, Little RF, [...] Zeidan AM
Blood Adv, 7(12):2709-2714, 01 Jun 2023
Cited by: 2 articles | PMID: 36260702 | PMCID: PMC10333740
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Updates in Classification of Myelodysplastic Syndrome.
Xu ML, Hasserjian RP
Cancer J, 29(3):122-129, 01 May 2023
Cited by: 0 articles | PMID: 37195767
Add to export list Review
Pediatric myelodysplastic syndrome.
Babcock S, Calvo KR, Hasserjian RP
Semin Diagn Pathol, 40(3):152-171, 14 Apr 2023
Cited by: 0 articles | PMID: 37173164
Add to export list Review

1-25 of 276 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype.

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology.

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.

Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.

A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.

Lymphoma Classifications, How to Develop a Future Unified Taxonomy.

Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study.

STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.

Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.

Diagnosis and classification of myelodysplastic syndromes.

Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.

Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury.

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.

Morphologic Characteristics of Myelodysplastic Syndromes.

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.

Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight.

The international consensus classification of eosinophilic disorders and systemic mastocytosis.

Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.

Updates in Classification of Myelodysplastic Syndrome.

Pediatric myelodysplastic syndrome.

Partnerships & funding